4-Chlorobenzoic acid , >=98 %, for synthesis, 1 kg, plastic packaging.

Dimethyl 2-nitroterephthalate, 95.0%, 500g

(Chloromethoxy)cyclohexane, 98%, 5g

5-Cyclopropyl-3-trifluoromethyl-1H-pyrazole, 95.0%, 5g

Benzyl (3-fluoro-4-(4-phenylpiperazin-1-yl)phenyl)carbamate, 97.0%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(((benzyloxy)carbonyl)amino)butanoic acid, 97%, 250mg

4-tert-butyl-N'-hydroxybenzene-1-carboximidamide, 100mg

(S)-3-((tert-Butoxycarbonyl)amino)-4-(3-cyanophenyl)butanoic acid, 97%, 1g

tert-Butyl (2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethoxy)ethyl)carbamate, 95%, 100mg

TOLAZAMIDE, 98%, 250mg

(3-(tert-Butylcarbamoyl)-4-chlorophenyl)boronic acid, 95.0%, 1g

di-tert-Butyl (S)-2-(2-hydroxyethyl)piperazine-1,4-dicarboxylate, 95+%, 250mg

1-Boc-4-(3-Formylphenyl)piperazine, 95.0%, 5g